Quadrant Capital Group LLC Neuro Pace Inc Transaction History
Quadrant Capital Group LLC
- $2.65 Billion
- Q1 2025
A detailed history of Quadrant Capital Group LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 44 shares of NPCE stock, worth $779. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44Holding current value
$779% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NPCE
# of Institutions
94Shares Held
29.9MCall Options Held
1.8KPut Options Held
300-
Kck Ltd. Tortola, D85.27MShares$93.4 Million78.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$60.4 Million1.3% of portfolio
-
Polar Capital Holdings PLC London, X02.97MShares$52.7 Million0.24% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.61MShares$46.2 Million2.65% of portfolio
-
Morgan Stanley New York, NY2.53MShares$44.8 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $440M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...